scanX
Narayana Hrudayalaya

Narayana Hrudayalaya

1,829.70
-115.80
(-5.95%)
Market Cap
37,391.90 Cr
EPS
38.90
PE Ratio
49.87
Dividend Yield
0.23 %
52 Week High
2,370.20
52 Week Low
1,171.00
PB Ratio
10.95
Debt to Equity
0.50
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from8 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+62.50 %
+62.50 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+37.50 %
+37.50 %

Company News

View All News
Caret
positive
Narayana Hrudayalaya Reports 15.4% Revenue Growth in Q1 FY26, Submits Revised Investor Presentation1 day ago
Narayana Hrudayalaya Limited submitted a revised investor presentation for the quarter ended June 30, 2025. The healthcare company reported consolidated operating revenues of ₹15,073 million in Q1 FY26, representing a 15.4% year-over-year increase and 2.2% quarter-over-quarter growth. The company achieved consolidated EBITDA of ₹3,607 million with a margin of 23.9% and consolidated profit after tax of ₹1,961 million with a margin of 13.0%. The company operates 40 healthcare facilities with 5,563 operational beds across India and Cayman Islands, including 18 owned/operated hospitals, 2 heart centers, and 18 clinics. Net debt to equity ratio stands at 0.09 with total borrowings less cash and investments of ₹3,430 million as of June 30, 2025. The company has expansion plans targeting over 7,600 bed capacity with multiple projects in progress across Bangalore, Kolkata, and Raipur.
positive
Narayana Health Reports Double-Digit Growth in Q1 FY26 with Strategic Expansion Plans3 days ago
Narayana Health achieved double-digit growth in Q1 FY26 while maintaining strong business momentum. The healthcare company is implementing strategic capital expenditure initiatives and pursuing deep technology-led transformation. The company is focusing on scalable healthcare expansion with an emphasis on ESG-driven operations.
neutral
Narayana Hrudayalaya Reports Mixed Q1 Results with Revenue Growth and Profit Decline3 days ago
Narayana Hrudayalaya reported quarterly consolidated net profit of 1.97 billion rupees, down from 2 billion rupees in the same period last year. Revenue increased to 15.07 billion rupees from 13.06 billion rupees year-over-year. EBITDA rose to 3.61 billion rupees from 3.26 billion rupees, while EBITDA margin declined to 23.93% from 24.94%. The company's board has requested permission to issue debt securities worth up to 25 billion rupees.

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Max Healthcare Institute
1,250.40
#1 1,21,557.24
107.13
7,184.10
18.77
1,076
26.84
51.09
Apollo Hospitals
7,308.00
1,05,077.83
73.03
#1 21,794.00
14.74
1,513
#1 60.41
49.10
Fortis Healthcare
861.90
65,069.84
76.92
7,849.70
8.99
809
-7.43
71.25
Narayana Hrudayalaya
1,829.70
#4 37,391.90
#1 49.87
#4 5,482.98
#9 10.96
#5 807
#6 -2.38
36.29
Global Health
1,324.50
35,574.40
69.32
3,692.32
#1 25.09
486
-20.35
59.13
Aster DM Healthcare
585.95
30,359.30
86.30
4,138.46
22.85
#1 5,417
-98.18
47.15
Krishna Institute of Medical Sciences
747.15
29,896.38
80.41
3,035.10
12.94
409
48.39
56.72
Rainbow Childrens Medicare
1,502.60
15,259.15
60.22
1,566.90
17.46
244
35.52
46.99
Jupiter Life Line Hospital
1,449.80
9,505.76
49.97
1,290.20
17.77
194
-1.57
44.17
Healthcare Global Enterprises
611.25
8,521.76
191.83
2,218.14
12.97
28
-55.88
65.52
Forecast
Actual
Growth Rate
Revenue Growth
10.96 %
Net Income Growth
30.17 %
Cash Flow Change
-1.66 %
ROE
-3.76 %
ROCE
-15.58 %
EBITDA Margin (Avg.)
7.25 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
365
378
409
400
432
455
492
459
489
526
565
558
653
655
714
735
776
782
829
791
750
398
611
755
846
867
952
967
951
1,041
1,173
1,140
1,236
1,249
1,324
1,222
1,273
1,331
1,424
1,353
1,503
1,532
Expenses
326
344
360
358
392
402
426
406
425
473
502
502
597
607
640
657
676
675
702
684
659
486
575
648
698
728
774
787
768
842
898
874
946
963
997
925
955
1,004
1,092
1,028
1,126
1,171
EBITDA
39
34
49
42
40
54
66
53
64
53
63
56
56
49
74
79
101
107
127
107
92
-87
36
107
148
139
179
180
182
200
275
266
290
286
327
297
318
327
332
325
377
361
Operating Profit %
10 %
8 %
11 %
10 %
8 %
11 %
13 %
11 %
12 %
9 %
10 %
9 %
8 %
7 %
10 %
10 %
12 %
13 %
15 %
13 %
11 %
-23 %
4 %
14 %
17 %
15 %
18 %
18 %
18 %
19 %
21 %
23 %
23 %
22 %
24 %
23 %
23 %
23 %
22 %
23 %
24 %
22 %
Depreciation
19
18
18
19
21
19
20
20
21
22
29
24
26
33
34
35
36
41
43
46
55
46
46
47
45
45
46
46
47
48
49
57
56
59
55
63
65
61
65
70
83
84
Interest
12
9
8
6
6
6
5
6
6
10
8
8
21
17
18
18
18
22
22
21
21
20
19
19
18
17
17
16
16
15
15
19
21
21
23
25
28
34
35
37
41
45
Profit Before Tax
10
10
26
20
13
29
41
28
37
21
26
24
9
-1
22
26
47
43
62
40
16
-153
-30
42
85
77
116
117
119
137
211
190
214
206
248
209
225
231
232
219
254
232
Tax
11
11
16
14
8
12
15
11
15
10
10
10
-1
3
8
13
10
13
17
9
4
-34
-26
1
17
1
17
20
50
27
42
36
40
22
22
21
34
30
33
26
57
35
Net Profit
-1
-1
10
6
5
17
27
17
22
11
17
14
10
-4
14
13
37
30
45
31
12
-120
-3
41
68
76
99
98
69
111
169
154
173
184
227
188
191
202
199
193
197
197
EPS in ₹
0.00
-0.03
0.52
0.29
0.25
0.85
1.31
0.84
1.10
0.54
0.82
0.70
0.48
-0.21
0.67
0.63
1.83
1.49
2.23
1.55
0.59
-5.90
-0.17
2.01
3.35
3.75
4.89
4.80
3.40
5.45
8.31
7.57
8.53
9.06
11.16
9.26
9.39
9.92
9.78
9.50
9.71
9.68
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
7,265
Fixed Assets
913
1,055
1,082
1,848
1,838
2,092
1,961
1,980
2,336
2,651
4,233
Current Assets
260
286
302
479
527
586
665
909
1,294
1,946
2,550
Capital Work in Progress
20
14
53
35
56
12
20
67
259
514
70
Investments
0
87
96
9
17
86
120
132
252
844
110
Other Assets
437
401
416
644
725
701
669
951
1,315
1,615
0
Total Liabilities
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
7,265
Current Liabilities
343
315
323
510
510
602
703
780
987
1,110
1,193
Non Current Liabilities
258
365
361
989
1,045
1,153
946
861
1,042
1,629
2,444
Total Equity
769
876
963
1,036
1,082
1,137
1,121
1,489
2,132
2,885
3,626
Reserve & Surplus
568
674
761
833
878
933
917
1,286
1,928
2,681
3,422
Share Capital
200
204
204
204
204
204
204
204
204
204
204
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-6
42
28
-22
89
8
-2
59
-4
97
Investing Activities
-223
-150
-146
-520
-162
-189
-113
-267
-1,176
-1,458
Operating Activities
77
174
219
182
279
443
304
485
1,085
1,067
Financing Activities
140
18
-45
315
-27
-247
-194
-159
88
489
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
11.60 %
0.00 %
10.91 %
10.01 %
9.68 %
9.44 %
9.66 %
10.46 %
DIIs
14.80 %
15.55 %
16.15 %
14.61 %
13.76 %
13.43 %
16.18 %
14.58 %
14.14 %
11.95 %
10.89 %
9.46 %
9.51 %
8.23 %
7.90 %
8.69 %
8.52 %
8.09 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
4.64 %
4.97 %
4.85 %
5.11 %
5.92 %
6.87 %
5.86 %
6.93 %
7.10 %
7.99 %
8.46 %
9.04 %
10.00 %
11.68 %
12.13 %
11.58 %
11.47 %
11.18 %
Others
16.71 %
15.63 %
15.14 %
16.43 %
16.46 %
15.85 %
14.11 %
14.64 %
14.90 %
16.20 %
5.20 %
17.65 %
5.73 %
6.23 %
6.43 %
6.43 %
6.50 %
6.42 %
No of Share Holders
0
36,360
44,526
43,565
43,807
52,747
65,173
68,130
75,370
86,631
1,02,994
1,20,506
1,38,052
1,60,686
1,78,356
1,77,792
1,85,787
2,05,639

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 1 1 0.00 1 2.5 4 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.4 0.25 0.00 0.13 0.19 0.24 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 29 Aug 2025 1,724.30 1,945.50
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 01 Aug 2025 1,991.45 1,916.05
01 Aug 2025 DIVIDEND Dividend
₹ 4.50 /share
 01 Aug 2025 1,724.30 1,916.05
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 May 2025 1,790.70 1,724.30
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 14 Feb 2025 1,372.70 1,329.00
31 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 31 Oct 2024 1,236.20 1,222.55
30 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 30 Aug 2024 1,255.10 1,265.50
02 Aug 2024 DIVIDEND Dividend
₹ 4.00 /share
 02 Aug 2024 1,255.10 1,252.75
07 Jul 2023 DIVIDEND Dividend
₹ 2.50 /share
 07 Jul 2023 767.85 1,012.95
23 Aug 2022 DIVIDEND Dividend
₹ 1.00 /share
 22 Aug 2022 659.80 705.15

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication9 hours ago
Announcement under Regulation 30 (LODR)-Investor Presentation1 day ago
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release3 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation3 days ago
Recommendation By The Board For The Issuance Of Non-Convertible Securities.3 days ago
Board Meeting Outcome for Outcome Of The Board Meeting For The Unaudited Financial Results For The Quarter Ended June 30 2025 3 days ago
Unaudited Financial Results For The Quarter Ended June 30 2025 3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025 And Fund Raising.7 days ago
Communication To Shareholders - Intimation On Tax Deduction On DividendJul 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 27, 2025
Closure of Trading WindowJun 27, 2025
Rumour verification - Regulation 30(11)Jun 26, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 25, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJun 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2025
Clarification To The Volume Movement Letter Dated May 27 2025 Received From BSE Ltd.May 27, 2025
Clarification sought from Narayana Hrudayalaya LtdMay 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2025
General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.May 23, 2025
General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.May 23, 2025
Shareholders MeetingMay 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 23, 2025
General Updates - Recommendation By The Board For The Issuance Of Non-Convertible Securities.May 23, 2025
Record Date - For DividendMay 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 23, 2025
Corporate Action-Board approves DividendMay 23, 2025
Board Meeting Outcome for Outcome Of The Board Meeting For The Financial Results For The Quarter And Year Ended March 312025May 23, 2025
Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2025May 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2025
Board Meeting Intimation for Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025 Dividend And Fund RaisingMay 16, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-RevisedApr 30, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 14, 2025
Rumour verification - Regulation 30(11)Apr 08, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 05, 2025
Intimation Regarding Agreement Between The Wholly Owned Subsidiary Of The Company- Narayana Vaishno Devi Specialty Hospitals Private Limited With Shri Mata Vaishnodevi Charitable SocietyMar 28, 2025
Closure of Trading WindowMar 26, 2025

Technical Indicators

RSI(14)
Neutral
36.29
ATR(14)
Volatile
65.83
STOCH(9,6)
Neutral
36.47
STOCH RSI(14)
Oversold
11.14
MACD(12,26)
Bearish
-17.26
ADX(14)
Strong Trend
25.27
UO(9)
Bearish
34.54
ROC(12)
Downtrend And Accelerating
-6.71
WillR(14)
Oversold
-83.63
Bearish
3
Neutral
4
Bullish
2

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Axis Momentum Fund Direct - Growth
3.68%
172889
2.86%
3.68%
DSP Healthcare Fund Direct - Growth
0.00%
-138465
-0.82%
-1.50%
DSP Small Cap Direct Plan-Growth
1.14%
-100000
0.07%
-0.10%
Union Active Momentum Fund Direct-Growth
2.95%
64668
2.95%
0.84%
DSP Focus Direct Plan-Growth
0.00%
-61982
-0.42%
-1.42%
Nippon India Nifty 500 Momentum 50 Index Fund Direct-Growth
1.12%
49565
1.12%
1.12%
Bandhan Nifty Alpha 50 Index Fund Direct-Growth
1.92%
44403
1.92%
1.92%
Motilal Oswal Nifty 500 Momentum 50 Index Fund Direct-Growth
1.12%
37112
1.12%
1.12%
DSP Multicap Fund Direct - Growth
0.00%
-34765
-0.27%
-0.70%
Samco Active Momentum Fund Direct - Growth
3.12%
23000
0.99%
0.98%
Mirae Asset Multicap Fund Direct - Growth
1.19%
-21138
0.07%
0.48%
Nippon India Active Momentum Fund Direct-Growth
1.85%
17215
1.85%
1.85%
Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund Direct-Growth
1.24%
14755
1.24%
1.24%
Axis Small Cap Fund Direct-Growth
2.07%
-7050
0.31%
0.17%
Nippon India Pharma Fund Direct-Growth
3.55%
-5135
0.61%
0.51%
Axis Nifty500 Momentum 50 Index Fund Direct-Growth
1.13%
4249
1.13%
1.13%
UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund Direct-Growth
1.17%
3851
1.17%
1.17%
Navi Large & Midcap Fund Direct-Growth
0.23%
3500
0.23%
0.23%
Navi Flexi Cap Fund Direct - Growth
0.25%
3000
0.25%
0.25%
Shriram Balanced Advantage Fund Direct - Growth
0.80%
2300
0.80%
0.80%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.73%
2095
0.11%
0.04%
Navi Aggressive Hybrid Fund Direct - Growth
0.26%
1500
0.26%
0.26%
Bandhan Nifty 500 Momentum 50 Index Fund Direct-Growth
1.12%
1337
1.12%
1.12%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.73%
907
0.11%
0.04%
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth
2.91%
558
0.59%
0.32%

About Narayana Hrudayalaya

Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years, -1 days)
Website
https://www.narayanahealth.org
Chairperson NameDEVI PRASAD SHETTY
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Fundamental Screeners
Candlestick Screeners
Technical Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104